2019 MASCC/ISOO Annual Meeting on Supportive Care in Cancer


 

Where Are We Going With Biosimilars in Oncology? Data Based on the New Frontier in HER2+ Tumors - Trastuzumab

832 views
September 10, 2019
0 Comments
Login to view comments. Click here to Login